Found: 8
Select item for more details and to access through your institution.
Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 6, p. 823, doi. 10.1007/s00432-008-0518-8
- By:
- Publication type:
- Article
Three-dimensional ultrasound imaging of breast cancer by a real-time intraoperative navigation system.
- Published in:
- Breast Cancer (13406868), 2005, v. 12, n. 2, p. 122, doi. 10.2325/jbcs.12.122
- By:
- Publication type:
- Article
Immunohistochemical detection of P-glycoprotein in breast cancer and its significance as a prognostic factor.
- Published in:
- Breast Cancer (13406868), 1997, v. 4, n. 4, p. 259, doi. 10.1007/BF02966518
- By:
- Publication type:
- Article
Usefulness of three-dimensional multidetector-row CT images for preoperative evaluation of tumor extension in primary breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 89, n. 2, p. 119, doi. 10.1007/s10549-004-1477-7
- By:
- Publication type:
- Article
Potential of Reduction in Total Tumor Volume Measured with 3D-MRI as a Prognostic Factor for Locally-Advanced Breast Cancer Patients Treated with Primary Chemotherapy.
- Published in:
- Breast Journal, 2008, v. 14, n. 6, p. 523, doi. 10.1111/j.1524-4741.2008.00642.x
- By:
- Publication type:
- Article
Preoperative Evaluation of Residual Tumor Extent by Three-Dimensional Magnetic Resonance Imaging in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
- Published in:
- Breast Journal, 2006, v. 12, n. 2, p. 130, doi. 10.1111/j.1075-122X.2006.00220.x
- By:
- Publication type:
- Article
Good Response to Paclitaxel Predicts High Rates of Pathologic Complete Response for Breast Cancer Patients Treated Preoperatively with Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide.
- Published in:
- Oncology, 2009, v. 77, n. 2, p. 134, doi. 10.1159/000229753
- By:
- Publication type:
- Article
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
- Published in:
- Cancer Science, 2009, v. 100, n. 6, p. 1062, doi. 10.1111/j.1349-7006.2009.01151.x
- By:
- Publication type:
- Article